A small peptide derived from Flt-1 (VEGFR-1) functions as an angiogenic inhibitor

FEBS Letters
D C TanR Ge

Abstract

Vascular endothelial growth factor (VEGF) is an angiogenic stimulator which functions through two endothelial specific tyrosine kinase receptors, Flt-1 and Flk-1. In this work, we show that an 11-amino acid peptide derived from the second immunoglobulin-like domain of Flt-1 functions as an angiogenic inhibitor in chick chorioallantoic membrane and inhibited VEGF-induced vascular permeability in Miles' assay without binding to VEGF directly. Circular dichroism and nuclear magnetic resonance analyses indicate that this peptide forms a stable extended structure in solution, presumably beta-sheet structure and is most likely existing as a dimer. Our results suggest that this small peptide functions as an angiogenic inhibitor by inhibiting VEGF function through a non-VEGF binding mechanism.

References

Jul 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·Y MyokenJ D Sato
Jan 1, 1992·The Journal of Clinical Investigation·L B JakemanN Ferrara
Nov 7, 1995·Proceedings of the National Academy of Sciences of the United States of America·L P AielloL E Smith
Nov 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·R L Kendall, K A Thomas
Feb 1, 1997·Endocrine Reviews·N Ferrara, T Davis-Smyth
Feb 24, 1997·Biochemical and Biophysical Research Communications·S A CunninghamT A Brock
Feb 20, 1999·The Journal of Biological Chemistry·C PiossekK H Thierauch
May 13, 1999·International Journal of Experimental Pathology·W P Leenders

❮ Previous
Next ❯

Citations

Mar 17, 2004·Toxicon : Official Journal of the International Society on Toxinology·R Manjunatha Kini
May 11, 2004·Biological & Pharmaceutical Bulletin·Kosuke Shimizu, Naoto Oku
Jul 2, 2003·Amino Acids·Y L Janin
Oct 21, 2003·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Xinnong Jiang, John R Couchman
Nov 12, 2009·Biochemical and Biophysical Research Communications·Hyun-Kyung Kim, Young Ae Joe
Jun 16, 2004·International Journal of Cancer. Journal International Du Cancer·Ping AnChengchao Shou
Jun 24, 2006·Circulation Research·Siun MurphyAly Karsan
Oct 30, 2014·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Christiane QuiniouSylvain Chemtob
Aug 30, 2003·The Journal of Biological Chemistry·Kevin H MayoArjan W Griffioen
Jun 1, 2005·The Journal of Biological Chemistry·Konerirajapuram N SulochanaRuowen Ge
May 6, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christiane QuiniouSylvain Chemtob
Mar 9, 2012·Chemical Communications : Chem Comm·Andrew G JamiesonAndrew D Hamilton
Aug 7, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Pedro M LacalStefania D'Atri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.